Scaling law characterizing the dynamics of the transition of HIV-1 to error catastrophe

Increasing the mutation rate, mu, of viruses above a threshold, mu(c), has been predicted to trigger a catastrophic loss of viral genetic information and is being explored as a novel intervention strategy. Here, we examine the dynamics of this transition using stochastic simulations mimicking within-host HIV-1 evolution. We find a scaling law governing the characteristic time of the transition: tau approximate to 0.6/(mu - mu(c)). The law is robust to variations in underlying evolutionary forces and presents guidelines for treatment of HIV-1 infection with mutagens. We estimate that many years of treatment would be required before HIV-1 can suffer an error catastrophe.

The SPL7013 dendrimer destabilizes the HIV-1 gp120-CD4 complex

The poly (l-lysine)-based SPL7013 dendrimer with naphthalene disulphonate surface groups blocks the entry of HIV-1 into target cells and is in clinical trials for development as a topical microbicide. Its mechanism of action against R5 HIV-1, the HIV-1 variant implicated in transmission across individuals, remains poorly understood. Using docking and fully atomistic MD simulations, we find that SPL7013 binds tightly to R5 gp120 in the gp120-CD4 complex but weakly to gp120 alone. Further, the binding, although to multiple regions of gp120, does not occlude the CD4 binding site on gp120, suggesting that SPL7013 does not prevent the binding of R5 gp120 to CD4. Using MD simulations to compute binding energies of several docked structures, we find that SPL7013 binding to gp120 significantly weakens the gp120-CD4 complex. Finally, we use steered molecular dynamics (SMD) to study the kinetics of the dissociation of the gp120-CD4 complex in the absence of the dendrimer and with the dendrimer bound in each of the several stable configurations to gp120. We find that SPL7013 significantly lowers the force required to rupture the gp120-CD4 complex and accelerates its dissociation. Taken together, our findings suggest that SPL7013 compromises the stability of the R5 gp120-CD4 complex, potentially preventing the accrual of the requisite number of gp120-CD4 complexes across the virus-cell interface, thereby blocking virus entry.

A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection

Objectives:To determine if there is a biological mechanism that explains the association between HIV disease progression and increased mortality with low circulating vitamin D levels; specifically, to determine if restoring vitamin D levels induced T-cell functional changes important for antiviral immunity.Design:This was a pilot, open-label, three-arm prospective phase 1 study.Methods:We recruited 28 patients with low plasma vitamin D (<50nmol/l 25-hydroxyvitamin D3), comprising 17 HIV+ patients (11 on HAART, six treatment-naive) and 11 healthy controls, who received a single dose of 200000IU oral cholecalciferol. Advanced T-cell flow cytometry methods measured CD4(+) T-cell function associated with viral control in blood samples at baseline and 1-month after vitamin D supplementation.Results:One month of vitamin D supplementation restored plasma levels to sufficiency (>75nmol/l) in 27 of 28 patients, with no safety issues. The most striking change was in HIV+ HAART+ patients, where increased frequencies of antigen-specific T cells expressing macrophage inflammatory protein (MIP)-1 - an important anti-HIV blocking chemokine - were observed, with a concomitant increase in plasma MIP-1, both of which correlated significantly with vitamin D levels. In addition, plasma cathelicidin - a vitamin D response gene with broad antimicrobial activity - was enhanced.Conclusion:Vitamin D supplementation modulates disease-relevant T-cell functions in HIV-infected patients, and may represent a useful adjunct to HAART therapy. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.

Influence of recombination on acquisition and reversion of immune escape and compensatory mutations in HIV-1

Following transmission, HIV-1 adapts in the new host by acquiring mutations that allow it to escape from the host immune response at multiple epitopes. It also reverts mutations associated with epitopes targeted in the transmitting host but not in the new host. Moreover, escape mutations are often associated with additional compensatory mutations that partially recover fitness costs. It is unclear whether recombination expedites this process of multi-locus adaptation. To elucidate the role of recombination, we constructed a detailed population dynamics model that integrates viral dynamics, host immune response at multiple epitopes through cytotoxic T lymphocytes, and viral evolution driven by mutation, recombination, and selection. Using this model, we compute the expected waiting time until the emergence of the strain that has gained escape and compensatory mutations against the new host's immune response, and reverted these mutations at epitopes no longer targeted. We find that depending on the underlying fitness landscape, shaped by both costs and benefits of mutations, adaptation proceeds via distinct dominant pathways with different effects of recombination, in particular distinguishing escape and reversion. When adaptation at a single epitope is involved, recombination can substantially accelerate immune escape but minimally affects reversion. When multiple epitopes are involved, recombination can accelerate or inhibit adaptation depending on the fitness landscape. Specifically, recombination tends to delay adaptation when a purely uphill fitness landscape is accessible at each epitope, and accelerate it when a fitness valley is associated with each epitope. Our study points to the importance of recombination in shaping the adaptation of HIV-1 following its transmission to new hosts, a process central to T cell-based vaccine strategies. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.

Transmissão vertical do hiv e transplante de fígado

"Aborda dois Projetos de Lei na área de saúde pública em tramitação no Congresso Nacional. As proposições referidas são: o Projeto de Lei n° 5522, de 2005, que dispõe sobre a obrigatoriedade da implementação de protocolo terapêutico para a prevenção da transmissão vertical do HIV, e o Projeto de Lei n.º 2.745, de 2003, que dispõe sobre as regras para elaboração da lista nacional de receptores de fígado do Sistema Nacional de Transplante."

Proceedings of the International Workshop responding to HIV and AIDS in the fishery sector in Africa, Lusaka, Zambia, 21-22 February 2006

The purpose of the workshop was to enable professionals and organizations working with fishing communities in response to HIV and AIDS in Africa to share experiences, appraise the efficacy of their approaches and identify actions in research and development that will further improve their impact. The workshop pursued and achieved the following objectives: 1)Review and compare research findings and approaches applied in response to HIV and AIDS in fishing communities and the wider fishery sector. 2)Identify good practice examples for wider application. 3)Identify next steps in development and research to scale up these examples. 4)Initiate a network of practitioners in Africa for capacity building, scaling-up and further development of approaches. The range of papers presented at the conference reveals the diversity of responses to HIV and AIDS in the fishery sector at all levels. The papers discussed a range of issues within this broad remit, from community level impacts of disease to policy implementation, from spatial mapping to theatre as a mode of communication. (Document contains 92 pages)

Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody : Implications for Anti-2F5 Immunogenicity

13 p.

Adapting integrated agriculture aquaculture for HIV and AIDS-affected households: the case of Malawi

The WorldFish Center in conjunction with World Vision Malawi carried out a project to improve income and nutrition status of households affected by HIV and AIDS with funding from the World Bank. The project was implemented in Southern Malawi particularly in the West of Zomba District from July 2005 to June 2006. Through participatory approaches, the project identified constraints that limit HIV and AIDS affected households’ realisation of the benefits from fish farming and adapted technologies and practices for the affected beneficiaries to boost fish production and utilization. Specifically, the project sought (1) to identify the constraints that limit HIV and AIDS affected households to realise the benefits from fish farming and based on the constraints, (2) to adapt technologies and practices for use by the affected beneficiaries to boost fish production and utilization. (PDF cotains 17 pages)

Statistical and econometric analysis of the treatment of HIV/AIDS

The epidemic of HIV/AIDS in the United States is constantly changing and evolving, starting from patient zero to now an estimated 650,000 to 900,000 Americans infected. The nature and course of HIV changed dramatically with the introduction of antiretrovirals. This discourse examines many different facets of HIV from the beginning where there wasn't any treatment for HIV until the present era of highly active antiretroviral therapy (HAART). By utilizing statistical analysis of clinical data, this paper examines where we were, where we are and projections as to where treatment of HIV/AIDS is headed.

Chapter Two describes the datasets that were used for the analyses. The primary database utilized was collected by myself from an outpatient HIV clinic. The data included dates from 1984 until the present. The second database was from the Multicenter AIDS Cohort Study (MACS) public dataset. The data from the MACS cover the time between 1984 and October 1992. Comparisons are made between both datasets.

Chapter Three discusses where we were. Before the first anti-HIV drugs (called antiretrovirals) were approved, there was no treatment to slow the progression of HIV. The first generation of antiretrovirals, reverse transcriptase inhibitors such as AZT (zidovudine), DDI (didanosine), DDC (zalcitabine), and D4T (stavudine) provided the first treatment for HIV. The first clinical trials showed that these antiretrovirals had a significant impact on increasing patient survival. The trials also showed that patients on these drugs had increased CD4+ T cell counts. Chapter Three examines the distributions of CD4 T cell counts. The results show that the estimated distributions of CD4 T cell counts are distinctly non-Gaussian. Thus distributional assumptions regarding CD4 T cell counts must be taken, into account when performing analyses with this marker. The results also show the estimated CD4 T cell distributions for each disease stage: asymptomatic, symptomatic and AIDS are non-Gaussian. Interestingly, the distribution of CD4 T cell counts for the asymptomatic period is significantly below that of the CD4 T cell distribution for the uninfected population suggesting that even in patients with no outward symptoms of HIV infection, there exists high levels of immunosuppression.

Chapter Four discusses where we are at present. HIV quickly grew resistant to reverse transcriptase inhibitors which were given sequentially as mono or dual therapy. As resistance grew, the positive effects of the reverse transcriptase inhibitors on CD4 T cell counts and survival dissipated. As the old era faded a new era characterized by a new class of drugs and new technology changed the way that we treat HIV-infected patients. Viral load assays were able to quantify the levels of HIV RNA in the blood. By quantifying the viral load, one now had a faster, more direct way to test antiretroviral regimen efficacy. Protease inhibitors, which attacked a different region of HIV than reverse transcriptase inhibitors, when used in combination with other antiretroviral agents were found to dramatically and significantly reduce the HIV RNA levels in the blood. Patients also experienced significant increases in CD4 T cell counts. For the first time in the epidemic, there was hope. It was hypothesized that with HAART, viral levels could be kept so low that the immune system as measured by CD4 T cell counts would be able to recover. If these viral levels could be kept low enough, it would be possible for the immune system to eradicate the virus. The hypothesis of immune reconstitution, that is bringing CD4 T cell counts up to levels seen in uninfected patients, is tested in Chapter Four. It was found that for these patients, there was not enough of a CD4 T cell increase to be consistent with the hypothesis of immune reconstitution.

In Chapter Five, the effectiveness of long-term HAART is analyzed. Survival analysis was conducted on 213 patients on long-term HAART. The primary endpoint was presence of an AIDS defining illness. A high level of clinical failure, or progression to an endpoint, was found.

Chapter Six yields insights into where we are going. New technology such as viral genotypic testing, that looks at the genetic structure of HIV and determines where mutations have occurred, has shown that HIV is capable of producing resistance mutations that confer multiple drug resistance. This section looks at resistance issues and speculates, ceterus parabis, where the state of HIV is going. This section first addresses viral genotype and the correlates of viral load and disease progression. A second analysis looks at patients who have failed their primary attempts at HAART and subsequent salvage therapy. It was found that salvage regimens, efforts to control viral replication through the administration of different combinations of antiretrovirals, were not effective in 90 percent of the population in controlling viral replication. Thus, primary attempts at therapy offer the best change of viral suppression and delay of disease progression. Documentation of transmission of drug-resistant virus suggests that the public health crisis of HIV is far from over. Drug resistant HIV can sustain the epidemic and hamper our efforts to treat HIV infection. The data presented suggest that the decrease in the morbidity and mortality due to HIV/AIDS is transient. Deaths due to HIV will increase and public health officials must prepare for this eventuality unless new treatments become available. These results also underscore the importance of the vaccine effort.

The final chapter looks at the economic issues related to HIV. The direct and indirect costs of treating HIV/AIDS are very high. For the first time in the epidemic, there exists treatment that can actually slow disease progression. The direct costs for HAART are estimated. It is estimated that the direct lifetime costs for treating each HIV infected patient with HAART is between $353,000 to $598,000 depending on how long HAART prolongs life. If one looks at the incremental cost per year of life saved it is only $101,000. This is comparable with the incremental costs per year of life saved from coronary artery bypass surgery.

Policy makers need to be aware that although HAART can delay disease progression, it is not a cure and HIV is not over. The results presented here suggest that the decreases in the morbidity and mortality due to HIV are transient. Policymakers need to be prepared for the eventual increase in AIDS incidence and mortality. Costs associated with HIV/AIDS are also projected to increase. The cost savings seen recently have been from the dramatic decreases in the incidence of AIDS defining opportunistic infections. As patients who have been on HAART the longest start to progress to AIDS, policymakers and insurance companies will find that the cost of treating HIV/AIDS will increase.

Vivendo com HIV/AIDS : cuidado, tratamento e adesão na experiência do grupo com vida

A presente dissertação aborda a adesão ao tratamento. Entendendo que tratamento não se restringe a prescrição e tomada de medicamentos, o Ambulatório de Medicina Integral do Hospital Universitário Pedro Ernesto (AMI/HUPE/UERJ) desenvolve um trabalho multidisciplinar com pacientes soropositivos. Durante o acompanhamento destes pacientes constatou-se a importância da criação de um espaço coletivo que permitisse a reflexão sobre o viver e conviver com HIV/AIDS. O Grupo COM VIDA começou as suas atividades em julho de 1996, contando com uma equipe multidisciplinar formada por médico, psicólogo e profissional do Serviço Social. Com a evolução do trabalho, a equipe foi lidando a cada dia mais e mais com as questões suscitadas pela terapia anti-retroviral. A adesão ao tratamento passou a ser um pilar no manejo do tratamento de pacientes com HIV/AIDS. A abordagem biopsicossocial do paciente constitui-se como facilitadora da adesão ao processo terapêutico. As variáveis que envolvem a intervenção terapêutica mencionada são consoantes ao processo de adoecimento humano que é complexo e dinâmico, na medida que pressupõe a capacidade de reagir para a pessoa que adoece tem um sentido e um significado. E tornando-se sujeito no processo de adoecimento e cuidado que o paciente desenvolve capacidade autônoma, o que contribui para alcançar os objetivos terapêuticos pactuados.

A constituição de 1988, as políticas públicas de saúde e o fornecimento de medicamentos para as pessoas portadoras de HIV/AIDS

A discussão sobre a atuação do Estado nas políticas públicas de Saúde remonta a constituição alemã de Weimar, em 1919 até os dias de hoje. No Brasil, esta discussão avança em dois momentos da década de 80: o primeiro é o registro dos casos de AIDS inicialmente detectados em 1980, enfermidade vista como problema de determinados grupos sociais de comportamentos desviantes e não da sociedade como um todo, acarretando movimento por parte da sociedade civil atingida pela doença, através de organizações não-governamentais que se especializaram na luta contra a discriminação do portador do vírus HIV e do doente de AIDS. O segundo momento é a promulgação da Constituição da República de 1988, texto normativo que estabeleceu diretrizes referentes ao fornecimento de serviços de saúde por parte do Estado, elevando a saúde a categoria de direito fundamental social. Estes movimentos liderados pelas organizações não-governamentais, pressionaram o Estado, através do Poder Judiciário para garantir o cumprimento de seus direitos de cidadãos previstos na Constituição, uma vez que o desrespeito aos direitos das pessoas que vivem com HIV/AIDS era crescente no Brasil. Para desenvolvimento da presente tese foi utilizada a pesquisa documental das decisões em todas as instâncias do Poder Judiciário, passando pelo Tribunal Estadual do Rio de Janeiro até chegar a cúpula do Poder Judiciário, o Supremo Tribunal Federal, aprofundando o estudo nas decisões que deferiram os pedidos referentes ao fornecimento de medicamentos para os doentes de AIDS. Foram utilizados documentos doutrinários para fundamentar a necessidade da aplicabilidade das normas constitucionais de forma imediata e não como meros programas para o poder público. Ao levantar estes documentos, observou-se que a previsão constitucional, e as decisões dos órgãos do Poder Judiciário, caminhavam não só para garantir os direitos das pessoas que vivem com HIV/AIDS, mas também para estender esta política pública a outras doenças degenerativas do organismo humano de forma a possibilitar a aplicação da previsão normativa não somente àquela doença.

Structure-Guided Design and Biophysical Characterization of Novel Anti-HIV Reagents

Despite over 30 years of effort, an HIV-1 vaccine that elicits protective antibodies still does not exist. Recent clinical studies have identified that during natural infection about 20% of the population is capable of mounting a potent and protective antibody response. Closer inspection of these individuals reveal that a subset of these antibodies, recently termed potent VRC01-like (PVL), derive exclusively from a single human germline heavy chain gene. Induced clonal expansion of the B cell encoding this gene is the first step through which PVL antibodies may be elicited. Unfortunately, naturally occurring HIV gp120s fail to bind to this germline, and as a result cannot be used as the initial prime for a vaccine regimen. We have determined the crystal structure of an important germline antibody that is a promising target for vaccine design efforts, and have set out to engineer a more likely candidate using computationally-guided rational design.

In addition to prevention efforts on the side of vaccine design, recently characterized broadly neutralizing anti-HIV antibodies have excellent potential for use in gene therapy and passive immunotherapy. The separation distance between functional Fabs on an antibody is important due to the sparse distribution of envelop spikes on HIV compared to other viruses. We set out to build and characterize novel antibody architectures by incorporating structured linkers into the hinge region of an anti-HIV antibody b12. The goal was to observe whether these linkers increased the arm-span of the IgG dimer. When incorporated, flexible Gly4Ser repeats did not result in detectable extensions of the IgG antigen binding domains, by contrast to linkers including more rigid domains such as β2-microglobulin, Zn-α2-glycoprotein, and tetratricopeptide repeats (TPRs). This study adds an additional set of linkers with varying lengths and rigidities to the available linker repertoire, which may be useful for the modification and construction of antibodies and other fusion proteins.

As formas de transmissão do HIV/AIDS determinando representações: um estudo de enfermagem entre adolescentes soropositivo

Este estudo objetivou analisar e comparar a incorporação psicossocial do HIV/AIDS entre adolescentes soropositivos considerando os diferentes meios de transmissão: vertical e sexual. Trata-se de um estudo de natureza descritiva, com abordagem qualitativa, fundamentado na teoria das representações sociais, na perspectiva da Psicologia Social. Foram estudados 30 adolescentes soropositivos atendidos em um Hospital Universitário do Rio de Janeiro. Foi utilizada como técnica de coleta de dados entrevistas semi-estruturadas e dois instrumentos de coleta: um questionário de caracterização dos sujeitos e um roteiro temático que guiou as entrevistas. As entrevistas foram gravadas e os conteúdos transcritos e analisados conforme a técnica de análise de conteúdo temática. O resultado evidenciou que o significado do HIV/AIDS para os sujeitos, numa análise geral, é marcado predominantemente por sentimentos negativos como medo e sofrimento. Imagens comuns aos dois grupos foram da morte e destruição, assim como o preconceito foi um importante conteúdo representacional. Ao comparar os dois grupos percebe-se que os elementos mais presentes na representação de adolescentes contaminados por relação sexual são sofrimento e o medo, com uma dimensão imagética associada à morte. O uso do preservativo também é outro conteúdo representacional marcante nos discursos deste grupo. A sexualidade está incorporada na representação relacionada às dificuldades com a mesma pós descoberta do vírus. Já os adolescentes contaminados por transmissão vertical tiveram como elementos mais presentes a aceitação e conformação da doença. O tratamento torna-se um importante conteúdo da representação para este grupo, relacionando-o ao cuidado à saúde e a imunodeficiência. Conclui-se, então, que a escolha do estudo das representações sociais e das técnicas de análise utilizadas foram pertinentes, pois permitiram identificar os principais elementos constituintes da representação social do HIV/AIDS, comparando as diferenças representacionais nos dois grupos de adolescentes estudados. Estes resultados servirão para reflexão crítica de profissionais de saúde , tanto na contribuição para repensar estratégias de educação em saúde para prevenção de DST/AIDS, quanto no posicionamento diante de adolescentes soropositivos.

A influência da feminilização da Aids sobre a prática da enfermeira em relação ao aleitamento materno

Trata-se de uma pesquisa qualitativa cujo objeto é a percepção da enfermeira sobre a prática do aleitamento materno no contexto da feminilização da Aids. Tem por objetivos: analisar a percepção das enfermeiras de maternidade sobre a prática do aleitamento materno e a feminilização da Aids e discutir a prática da enfermeira em relação ao aleitamento materno a partir da feminilização da Aids. Os sujeitos do estudo foram nove enfermeiras de três maternidades municipais do Rio de Janeiro que possuem título de Hospitais Amigo da Criança. A coleta de dados foi realizada através de entrevistas semi-estruturadas. A técnica de análise do conteúdo foi baseada em Bardin. Emergiram três categorias: a) A percepção da enfermeira sobre sua prática quanto ao aleitamento materno; b) As percepções da enfermeira sobre a feminilização da Aids; c) A prática da enfermeira em relação ao aleitamento materno a partir da feminilização da Aids. Constatamos que a enfermeira percebe sua prática em relação ao aleitamento materno sob influência das Políticas Públicas voltadas para a promoção e proteção do mesmo, como a Iniciativa Hospital Amigo da Criança e o Alojamento Conjunto. Em relação à Aids, o advento da feminilização surpreende as enfermeiras que reagem com indignação, tristeza, medo e angústia. Estes sentimentos justificam-se, pois, para elas, pensar soropositividade em mulheres significa privá-las de exercer sua saúde reprodutiva e sexual plenamente, ou seja, os papéis esperados socialmente de uma mulher, como ser mãe e amamentar. A condição social e sexual da mulher (gênero) também emergiu dos depoimentos como determinantes para soropositividade. Ao perceberem sua prática às mulheres soropositivas nas maternidades, as enfermeiras apontam dificuldades geradas pela dicotomia (incentivo ao aleitamento materno e inibição da lactação) tanto para elas profissionais quanto para as mulheres que não podem amamentar. O processo de feminilização e os investimentos e recursos voltados para este acarretaram mudanças na prática da enfermeira, que refere mais segurança pessoal após disponibilização de teste rápido para HIV e cursos de capacitação para os profissionais. Além da prática voltada para as questões técnicas, apontam uma nova abordagem às mulheres soropositivas, como o objetivo de não expô-las às outras puérperas nas enfermarias de alojamento conjunto. Desta maneira, constatamos que as mudanças ocorridas nas práticas das enfermeiras estão relacionadas com o estabelecimento de políticas públicas voltadas para a amamentação e o HIV/Aids. Os valores pessoais ainda interferem na prática das enfermeiras, e a Aids ainda é vista como uma doença possuidora de estigmas tanto sociais quanto culturais. Reforçamos a necessidade de estratégias que possam diminuir a divergência das Políticas de Incentivo ao Aleitamento Materno e as de Prevenção à Transmissão Vertical, a fim de qualificar a prática de enfermagem às mulheres soropositivas.